BCLAF1 antibody (AA 272-321)
Quick Overview for BCLAF1 antibody (AA 272-321) (ABIN2884877)
Target
See all BCLAF1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 272-321
-
Specificity
- BCLAF1 Antibodyantibody detects endogenous levels of BCLAF1.
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide from human BCLAF1 (aa272-321).
Type of Immunogen: Synthetic peptide -
Isotype
- IgG
-
-
-
-
Application Notes
- Approved: Peptide-ELISA (1:10000), WB (1:500 - 1:1000)
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.4, 150 mM sodium chloride, 0.02 % sodium azide, 50 % glycerol
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C.
-
-
- BCLAF1 (BCL2-Associated Transcription Factor 1 (BCLAF1))
-
Alternative Name
- BTF / BCLAF1
-
Background
-
Name/Gene ID: BCLAF1
Family: Apoptosis
Synonyms: BCLAF1, BK211L9.1, BTF, KIAA0164 -
Gene ID
- 9774
-
UniProt
- Q9NYF8
-
Pathways
- Positive Regulation of Response to DNA Damage Stimulus
Target
-